19-16892978-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_015692.5(CPAMD8):c.*130A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.542 in 766,154 control chromosomes in the GnomAD database, including 115,631 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.59 ( 27645 hom., cov: 32)
Exomes 𝑓: 0.53 ( 87986 hom. )
Consequence
CPAMD8
NM_015692.5 3_prime_UTR
NM_015692.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.58
Genes affected
CPAMD8 (HGNC:23228): (C3 and PZP like alpha-2-macroglobulin domain containing 8) This gene encodes a member of the protease inhibitor I39 (alpha-2-macroglobulin) family of proteins. These proteins are important in innate and acquired immunity. The encoded protein is membrane-associated and proteolytically processed to generate two chains. Mutations in this gene cause a form of anterior segment dysgenesis, a developmental disorder of the eye. [provided by RefSeq, May 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BP6
Variant 19-16892978-T-G is Benign according to our data. Variant chr19-16892978-T-G is described in ClinVar as [Benign]. Clinvar id is 1240872.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.744 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CPAMD8 | NM_015692.5 | c.*130A>C | 3_prime_UTR_variant | 42/42 | ENST00000443236.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CPAMD8 | ENST00000443236.7 | c.*130A>C | 3_prime_UTR_variant | 42/42 | 1 | NM_015692.5 | P2 | ||
CPAMD8 | ENST00000651564.2 | c.*1438A>C | 3_prime_UTR_variant | 42/42 | A2 | ||||
CPAMD8 | ENST00000596224.5 | n.2097A>C | non_coding_transcript_exon_variant | 3/3 | 2 | ||||
CPAMD8 | ENST00000600235.5 | n.3462A>C | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.593 AC: 90132AN: 151940Hom.: 27591 Cov.: 32
GnomAD3 genomes
AF:
AC:
90132
AN:
151940
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.533 AC: 127013AN: 238208Hom.: 34819 AF XY: 0.535 AC XY: 69778AN XY: 130342
GnomAD3 exomes
AF:
AC:
127013
AN:
238208
Hom.:
AF XY:
AC XY:
69778
AN XY:
130342
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.529 AC: 325088AN: 614096Hom.: 87986 Cov.: 3 AF XY: 0.532 AC XY: 178020AN XY: 334760
GnomAD4 exome
AF:
AC:
325088
AN:
614096
Hom.:
Cov.:
3
AF XY:
AC XY:
178020
AN XY:
334760
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.594 AC: 90258AN: 152058Hom.: 27645 Cov.: 32 AF XY: 0.593 AC XY: 44088AN XY: 74326
GnomAD4 genome
AF:
AC:
90258
AN:
152058
Hom.:
Cov.:
32
AF XY:
AC XY:
44088
AN XY:
74326
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1658
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 10, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at